{"id":177,"date":"2014-05-25T00:09:02","date_gmt":"2014-05-25T00:09:02","guid":{"rendered":"https:\/\/www.newyorkurologyspecialists.com\/prostate-cancer\/?page_id=177"},"modified":"2026-10-17T04:18:19","modified_gmt":"2026-10-17T04:18:19","slug":"xofigo-radium-223","status":"publish","type":"page","link":"https:\/\/www.newyorkurologyspecialists.com\/prostate-cancer\/xofigo-radium-223\/","title":{"rendered":"Xofigo (Radium \u2013 223) for Treatment of Prostate Cancer"},"content":{"rendered":"
If you have any questions, to schedule a consultation<\/a> or if you need a second opinion<\/a>, please <\/a>contact us<\/a> or call: 646-663-5515<\/a><\/strong><\/p>\n On May 15, 2013, the U.S. Food and Drug Administration (FDA) approved Radium-223 dichloride to treat men with symptomatic metastatic castration-resistant prostate cancer that has spread to bones but not to other organs.<\/span><\/p>\n Xofigo is a radiopharmaceutical that has been shown to be beneficial for men with metastatic prostate cancer. Xofigo leads to decreased pain, improved quality of life, and improved survival.<\/p>\n If you have any questions, to schedule a consultation<\/a> or if you need a second opinion<\/a>, please <\/a>contact us<\/a> or call: 646-663-5515<\/a><\/strong><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" Xofigo (Radium \u2013 223) for Treatment of Prostate Cancer If you have any questions, to schedule a consultation or if you need a second opinion, please contact us or call: 646-663-5515 Xofigo for Treatment of Metastatic CRPC with Bony Metastasis. On May 15, 2013, the U.S. Food and Drug Administration (FDA) approved Radium-223 dichloride to treat men with symptomatic […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"ngg_post_thumbnail":0,"_top_nav_excluded":false,"_cms_nav_minihome":false,"_cms_nav_section":"","_cms_nav_offsite_url":"","footnotes":""},"class_list":["post-177","page","type-page","status-publish","hentry"],"yoast_head":"\n
\nXofigo for Treatment of Metastatic CRPC with Bony Metastasis.<\/h2>\n
\n
\n